Key Insights

Highlights

Success Rate

79% trial completion

Published Results

54 trials with published results (23%)

Research Maturity

117 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

13.5%

31 terminated out of 230 trials

Success Rate

79.1%

-7.5% vs benchmark

Late-Stage Pipeline

17%

39 trials in Phase 3/4

Results Transparency

46%

54 of 117 completed with results

Key Signals

54 with results79% success31 terminated

Data Visualizations

Phase Distribution

171Total
Not Applicable (28)
Early P 1 (6)
P 1 (27)
P 2 (71)
P 3 (25)
P 4 (14)

Trial Status

Completed117
Unknown38
Terminated31
Recruiting22
Withdrawn10
Not Yet Recruiting8

Trial Success Rate

79.1%

Benchmark: 86.5%

Based on 117 completed trials

Clinical Trials (230)

Showing 20 of 20 trials
NCT02858323CompletedPrimary

Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

NCT07696767Early Phase 1Not Yet RecruitingPrimary

Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation

NCT07682246Not Yet RecruitingPrimary

EFFECT OF PLATELET CONCENTRATE TRANSFUSION ON MICROCIRCULATORY ENDOTHELIAL FUNCTION IN INTENSIVE CARE UNIT

NCT03515447CompletedPrimary

Romiplostim in Thoracic Transplantation

NCT07653672Not Yet RecruitingPrimary

Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia

NCT04800458Not ApplicableRecruitingPrimary

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

NCT07616349RecruitingPrimary

Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.

NCT04889326Withdrawn

Collection of the Thrombo-VaxCov Cohort

NCT07441720Phase 2RecruitingPrimary

Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)

NCT07025512Phase 2Withdrawn

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

NCT06187831Completed

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger

NCT04837703UnknownPrimary

Managed Access Programs for ETB115, Eltrombopag

NCT06886516Early Phase 1Recruiting

Apixaban in Thrombocytopenia

NCT04673266Phase 2Completed

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

NCT06676904Not ApplicableRecruitingPrimary

Neonatal Platelet Transfusion Threshold Trial

NCT06788691Phase 2Recruiting

Luspatercept for Clonal Cytopenias of Uncertain Significance

NCT06521931Phase 1CompletedPrimary

A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

NCT07442513Phase 3Recruiting

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

NCT05255003Phase 4Recruiting

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

NCT06768619Not ApplicableCompletedPrimary

Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State

Scroll to load more

Research Network

Activity Timeline